Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non Operating Investment Income: 2022-2025

Historic Non Operating Investment Income for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to $29,000.

  • Orchestra BioMed Holdings' Non Operating Investment Income fell 76.03% to $29,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$183,000, marking a year-over-year increase of 24.07%. This contributed to the annual value of -$68,000 for FY2024, which is 277.78% down from last year.
  • According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Non Operating Investment Income is $29,000, which was up 238.10% from -$21,000 recorded in Q2 2025.
  • Orchestra BioMed Holdings' Non Operating Investment Income's 5-year high stood at $1.7 million during Q2 2022, with a 5-year trough of -$314,000 in Q3 2022.
  • For the 3-year period, Orchestra BioMed Holdings' Non Operating Investment Income averaged around -$19,909, with its median value being -$23,000 (2024).
  • Within the past 5 years, the most significant YoY rise in Orchestra BioMed Holdings' Non Operating Investment Income was 193.31% (2023), while the steepest drop was 103.53% (2023).
  • Quarterly analysis of 4 years shows Orchestra BioMed Holdings' Non Operating Investment Income stood at -$165,000 in 2022, then plummeted by 78.18% to -$294,000 in 2023, then surged by 40.14% to -$176,000 in 2024, then plummeted by 76.03% to $29,000 in 2025.
  • Its last three reported values are $29,000 in Q3 2025, -$21,000 for Q2 2025, and -$15,000 during Q1 2025.